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Abstract
We report herein an immunoglobulin A nephropathy patient with a long history of 32 years in the
relatively poor prognosis group according to pathological findings. In general, such cases in the
relatively poor prognosis group develop end-stage renal failure, and undergo dialysis within 5 to
20 years. However, the period from the appearance of proteinuria to hemodialysis was very long in
this patient. His mean blood pressure remained at approximately 100 mm Hg with the administration
of some antihypertensive agent. The genotype of the angiotensin converting enzyme was II. Although
normal renal function continued for the duration, he had severe acute tonsillitis at 45 and 49 years
of age. After these infections, proteinuria and/or hematuria were exacerbated and he gradually
progressed to end-stage renal failure. The good prognosis in this patient might be attributable to
good control of blood pressure, whereas the decline in renal function might be attributable to severe
recurrent upper respiratory tract infection. It seems that control of blood pressure and prevention of
recurrent upper respiratory tract infection are important factors in the prognosis of patients with
immunoglobulin A nephropathy. Although the association between angiotensin converting enzyme
genotype and prognosis of immunoglobulin A nephropathy is controversial, it is postulated that
angiotensin converting enzyme genotype II might be correlated with the good prognosis in this
case.
Key words: Angiotensin converting enzyme gene polymorphism, Immunoglobulin A nephropathy, Reciprocal
serum creatinine, Tonsillitis
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C A S E
R E P O R T
INTRODUCTION
Patients with immunoglobulin (Ig) A nephropathy are
classified into four groups at the time of renal biopsy
according to a system developed by a joint committee of
the Ministry of Health and Welfare of Japan and the
Japanese Society of Nephrology (1). They are the good
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chronic renal failure (3). This analysis may help to
estimate the progression of the disease. Changes of
reciprocal s-Cr levels in our patient from the first medical
examination in Juntendo University Hospital to the
present are shown in Figure 3. The slope of reciprocal s-
Cr levels is divided into three parts. The first slope
indicates renal function from the beginning of the
prognosis group, relatively good prognosis group,
relatively poor prognosis group, and poor prognosis
group. It is generally considered that development and
exacerbation of IgA nephropathy are frequently preceded
by episodes of recurrent upper respiratory tract infection.
Certain viral antigens might be related to the upper
respiratory tract infection in patients with IgA
nephropathy. Hematuria and/or proteinuria are usually
exacerbated after upper respiratory infections (2).
We experienced a patient with IgA nephropathy who had
a good prognosis despite being classified in the relatively
poor prognosis group according to pathological findings.
CASE REPORT
A 31-year-old man was admitted to Juntendo University
Hospital for investigation of microscopic hematuria and
proteinuria on 7 February 1974. When he was 26 years
old, proteinuria was pointed out in a medical checkup,
but he did not have another checkup for 5 years. He had
no remarkable medical or familial history.
On physical examination, his blood pressure was 130/
70 mm Hg in the supine position. Pharyngeal tonsils
showed slight swelling. There was no evidence of
peripheral edema or purpura. Levels of urinary protein
excretion were 272 mg/dL, and 24-hour urinary protein
excretion was 2.2 g. Urinary sediments showed a few
red blood cells with hyaline and granular casts. Initial
laboratory findings are shown in Table 1. In peripheral
blood, hemoglobin was 14.9 g/dL, red blood cells 468 x
104/µL, and white blood cells 5300/µL. The blood urea
nitrogen was 21 mg/dL, serum creatinine (s-Cr) 1 mg/
dL, total protein 7.4 g/dL, and serum albumin 4.5 g/dL.
The titers of antistreptolysin and antistreptokinase were
160 TU and 2560 times, respectively. The 50%
complement hemolytic units level in sera was within
normal limits. The creatinine clearance was 79.8 mL/
min. Urine cultures were negative for mycobacteria.
A renal biopsy was performed on February 19, 1974.
Four of 19 glomeruli were globally sclerosed. One
glomerulus showed adhesion to Bowman's capsule.
Three glomeruli showed marked proliferation of
mesangial cells and focal para-mesangial deposits in the
mesangial areas. Interstitial fibrosis and lymphocyte
infiltration were observed over a 20% area of the renal
cortex (Fig. 1). In immunofluorescence, IgA, IgG, and
C3 were deposited in the glomerular mesangial areas.
The genotype of the angiotensin converting enzyme
(ACE) polymorphism was II, as shown in Figure 2.
Commonly, it is recognized that reciprocal s-Cr
concentration correlates linearly with progression of
Laboratory tests Results
Hematologic test
   WBC 5300/µL
   RBC 468 x 104/µL
   Hemoglobin 14.9 g/dL
   Hematocrit 42.8%
   Platelet 21 x 104/µL
   ESR 3 mm/hour
Serological test
   CRP test (-)
   CH50 26.3
   Antistreptolysin 160 TU
   Antistreptokinase 2560 times
Biochemical test
   Total protein 7.4 g/dL
   Albumin 4.5 g/dL
   AST 19 U
   ALT 13 U
   LDH 210 U
   ALP 50 U
   BUN 21 mg/dL
   Creatinine 1 mg/dL
   Uric acid 6 mg/dL
   Na 146 mEq/L
   K 4.1 mEq/L
   Cl 107 mEq/L
   Ca 4.9 mEq/L
   P 3.7 mg/dL
   Total cholesterol 167 mg/dL
   Triglycerides 114 mg/dL
Urinalysis
   Protein 2.2 g/day
   Sugar (-)
Sediments
   WBC 1-5/HPF
   RBC 5-10/HPF
   Casts Hyaline (+)
Granular (+)
Renal function
   CCr 79.8 mL/min
WBC = white blood cell count; RBC = red blood cell count; ESR =
erythrocyte sedimentation rate; CRP = C-reactive protein; CH50 =
50% complement hemolytic units; AST = aspartate amino-
transferase; ALT = alanine aminotransferase; LDH = lactate
dehydrogenase; ALP =alkaline phosphatase; BUN = blood urea
nitrogen; HPF = high power field; CCr = creatinine clearance
Table 1. Laboratory data at first admission to the Juntendo
University Hospital.
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examination in Juntendo University Hospital).
Thereafter, the levels of urinary protein excretion
decreased to 76 mg/dL. However, urinary sediments
showed granular casts, white blood cell casts, and red
blood cell casts. The second slope indicates his renal
function from 19 to 24 years. He had a severe upper
respiratory infection in December 1987 (19 years).
Proteinuria and hematuria were exacerbated after the
observations to 19 years. It shows stable renal function.
The patient had been treated with dipyridamole (150 mg/
day) from 1985 (17 years from the first medical
Figure 1. (A) Light-microscopic findings. Glomerular sclerosis and
interstitial lymphocyte infiltrations were observed. Periodic acid-Schiff
staining 100x. (B) Focal-segmental proliferation of mesangial cells
and mesangial matrix expansion, and focal adhesion to Bowman's
capsules (arrow) were observed. Periodic acid-Schiff staining 400x.
Figure 2. Electrophoresis in agarose gel. Genomic DNA was
extracted from whole blood and then polymerase chain reaction
was performed. The angiotensin converting enzyme II genotype
was determined by the presence of the 500 base pair fragment
(1).
Figure 3. Changes of reciprocal serum creatinine (s-Cr) levels. The slope of reciprocal s-Cr
levels was divided into three parts.
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severe infection. The level of urinary protein excretion
was 1020 mg/dL. Urinary sediments showed 20 to 25
red blood cells/high power field. The levels of s-Cr were
also increased by the infection. After 24 years, the slope
of reciprocal s-Cr had decreased markedly because of
the second severe upper respiratory tract infection (Fig.
3). He had a severe recurrent upper respiratory infection
in September 1992 (24 years) with proteinuria and
microscopic hematuria exacerbated in the same way.
Urinalysis showed urinary protein excretion of 479 mg/
dL and 20 to 25 red blood cells/high power field in the
sediments. During both severe infections, the patient was
administered several antibiotics and antipyretics, such as
ampicillin, cefteram pivoxil, or sulindac for several days.
Although his blood pressure remained in good control
(mean blood pressure approximately 100 mm Hg) until
23 years without any antihypertensive agents (Fig. 4), it
was gradually increased because of exacerbation of renal
function. He was not treated with ACE inhibitors because
treatment with such drugs was not used for non-
hypertensive patients with IgA nephropathy. Finally, he
was given the antihypertensive nilvadipine (2 mg/day),
in 1997 (28 years after initial presentation). The levels
of blood pressure were approximately 150/96 mm Hg at
that time. Because all therapy was ineffective, he
progressed to end-stage renal failure (ESRF), and was
placed on hemodialysis 24 June 2000 (32 years after
initial presentation). However, we could not perform re-
biopsy of renal tissues because of his disagreement.
DISCUSSION
Immunoglobulin A nephropathy was initially described
as one type of glomerulonephritis with a good prognosis
(4). However, progression to ESRF including
hemodialysis or continuous ambulatory peritoneal
dialysis is not as rare as originally thought. Progressive
and/or exacerbating factors reported previously for this
disease have been male sex, old age, hypertension,
massive proteinuria, and prolonged duration (5).
Recurrent upper respiratory tract infection is also an
important factor of poor prognosis (2).
Histologically, mesangial cell proliferation and increased
extracellular matrix, glomerulosclerosis, crescent
formation or adhesion to Bowman's capsules, interstitial
fibrosis, and vascular sclerosis are factors for poor
prognosis in patients with IgA nephropathy (4,6,7).
Patients with IgA nephropathy are classified into the
following four groups at the time of renal biopsy
according to the criteria of the joint committee of the
Ministry of Health and Welfare of Japan and the Japanese
Society of Nephrology (1): 1. good prognosis group:
almost no possibility of dialysis; 2. relatively good
prognosis group: possibility of dialysis is relatively low;
3. relatively poor prognosis group: dialysis is likely to
be required within 5 to 20 years; and 4. poor prognosis
group: the possibility of dialysis within 5 years is high.
Among such clinical guidelines of IgA nephropathy, the
light-microscopic findings can be summarized as
follows: (a) Glomerular findings: 1. good prognosis
group: slight mesangial cell proliferation and increased
matrix. Glomerulosclerosis, crescent formation, or
adhesion to Bowman's capsule are not observed; 2.
relatively good prognosis group: slight mesangial cell
proliferation and increased matrix. Glomerulosclerosis,
crescent formation, or adhesion to Bowman's capsule
seen in less than 10% of all biopsied glomeruli; 3.
Figure 4. Mean blood pressure (squares) and serum creatinine (s-Cr) level (triangles) during
the observation period.
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relatively poor prognosis group: moderate, diffuse
mesangial cell proliferation and increased matrix.
Glomerulosclerosis, crescent formation, or adhesion to
Bowman's capsule seen in 10% to 30% of all biopsied
glomeruli; and 4. poor prognosis group: severe, diffuse
mesangial cell proliferation and increased matrix.
Glomerulosclerosis, crescent formation, or adhesion to
Bowman's capsule seen in more than 30% of all biopsied
glomeruli. When sites of sclerosis are totaled and
converted to global sclerosis, the sclerosis rate is more
than 50% of glomeruli. Some glomeruli also show
compensatory hypertrophy. The sclerosis rate is the most
important of these indices for evaluation of prognosis.
(b) Interstitial and vascular findings: 1. good prognosis
group: prominent changes are not seen in the interstitium,
renal tubuli, or blood vessels; 2. relatively good prognosis
group: same as above; 3. relatively poor prognosis group:
cellular infiltration is slight in the interstitium except
around some sclerosed glomeruli. Tubular atrophy is
slight, and mild vascular sclerosis is observed; and 4.
poor prognosis group: interstitial cellular infiltration,
tubular atrophy, and fibrosis are seen. Hyperplasia or
degeneration may be seen in some intrarenal arteriolar
walls (1).
This patient was diagnosed as in the relatively poor
prognosis group, because poor prognostic findings were
recognized histologically. Accordingly, moderate
mesangial cell proliferation and increased matrix were
shown. Glomerulosclerosis and adhesion to Bowman's
capsule were seen in 25% of all biopsied glomeruli, in
addition to interstitial cellular infiltration. Furthermore,
urinary sediments have shown white blood cell casts,
red blood cell casts, and granular casts from the early
stage of follow-up duration. It is generally considered
that dialysis will be required within 5 to 20 years (1).
According to the Haas grading system, this patient was
diagnosed as subclass III (8). Renal survival in cases
with crescents and/or interstitial inflammatory cell
infiltrations was significantly worse than in cases without
them in subclass III. According to Haas, more than 50%
of patients in subclass III with crescents and/or interstitial
inflammatory cell infiltration will require dialysis or renal
transplantation within 10 years from the date of biopsy
(8). However, this case showed a long duration of 32
years from the appearance of proteinuria to hemodialysis.
In this case, the patient showed a good prognosis although
his renal histological findings had already progressed at
the time of renal biopsy. His mean blood pressure levels
were well controlled (approximately 100 mm Hg) for a
long period with administration of some antihypertensive
agent. Strict control of blood pressure is one of the most
important factors for good prognosis in patients with IgA
nephropathy. The common international strategy adopted
at present is based on blood pressure control by
administration of antihypertensive agents in addition to
appropriate physical exercise and dietary protein
restrictions (9). However, this patient had practiced no
physical exercise or diet therapy. It is suggested that,
essentially, strict control of blood pressure contributed
to his good prognosis.
Several recent studies have shown a significant
association between ACE gene polymorphism and
progression to ESRF in patients with IgA nephropathy
(10,11). It has been reported that the rate of reduction of
renal function in patients with the DD or ID genotype of
ACE was significantly higher than that of patients with
the II genotype (10). However, several studies have
reported that no association was observed between
insertion/deletion polymorphism of the ACE gene and
renal progression in IgA nephropathy (12,13). The ACE
polymorphism genotype of this patient was II, which is
postulated as a possible reason for the good prognosis.
The main exacerbating factor for his renal function might
be severe recurrent upper respiratory tract infections.
After severe infections, his renal function deteriorated,
and hematuria, proteinuria, and s-Cr levels were
exacerbated. The titers of antistreptolysin and
antistreptokinase after tonsillitis were within normal
limits, and the number of eosinophils in peripheral blood
did not increase. Therefore, the possibility of
poststreptococcal glomerulonephritis and/or allergic
interstitial nephritis seemed to be ruled out. Because his
blood pressure became uncontrollable in recent years,
his renal function deteriorated further.
In conclusion, it seems that severe recurrent upper
respiratory tract infection is an important prognostic
factor in patients with IgA nephropathy. Strict control
of blood pressure, prevention of upper respiratory tract
infection, and its treatment at an early stage are important
in patients with IgA nephropathy.
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